<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03005353</url>
  </required_header>
  <id_info>
    <org_study_id>CSE</org_study_id>
    <nct_id>NCT03005353</nct_id>
  </id_info>
  <brief_title>Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Cream.</brief_title>
  <official_title>Randomized Clinical Trial for Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Cream.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fungal infections have increased over the last two decades, largely because of the increasing
      size of the population at risk, including patients who are immunocompromised, broad-spectrum
      antibiotics and intravascular catheter users. Essential oils and other extracts of plants
      have evoked interest as sources of natural products. They have been shown to possess
      antibacterial, antifungal, antiviral, insecticidal and antioxidant properties. To the best of
      our knowledge, no study has examined the efficacy of cumin seed extract on relieving
      vulvovaginal candidiasis in vivo.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2017</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of patients with complete cure</measure>
    <time_frame>one week</time_frame>
    <description>cure is defines as absence of symptoms</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Infection, Fungal</condition>
  <arm_group>
    <arm_group_label>Cumin seed extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group A (study group) will receive Cumin seed extract vaginal cream once daily for 7 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>clotrimazole</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B will receive conventional clotrimazole vaginal cream once daily for 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cumin seed extract</intervention_name>
    <description>patients will receive the drug in suppository form</description>
    <arm_group_label>Cumin seed extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clotrimazole</intervention_name>
    <description>patients will receive the drug in suppository form</description>
    <arm_group_label>clotrimazole</arm_group_label>
    <other_name>Gyno-Daktarin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women were 18-49 years old and were married;

          2. They had not used antibiotics, immunosuppressive drugs, or vaginal drugs 14 days
             before the study;

          3. They did not suffer from trichomonal vaginitis, bacterial vaginitis, or cervicitis
             based on direct smear;

          4. Candidiasis culture was in agreement with clinical symptoms and patient's complaints.

        Exclusion Criteria:

          1. Pregnant and lactating women;

          2. Those who had abnormal uterine bleeding;

          3. Women with diabetes or autoimmune diseases;

          4. Women refuse to participate in the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2016</study_first_submitted>
  <study_first_submitted_qc>December 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2016</study_first_posted>
  <last_update_submitted>November 11, 2017</last_update_submitted>
  <last_update_submitted_qc>November 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Abbas</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vulvovaginitis</mesh_term>
    <mesh_term>Mycoses</mesh_term>
    <mesh_term>Candidiasis, Vulvovaginal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

